Conductivity is one of the most critical parameters for determining the quality of purified water and water for injection (WFI) in the pharmaceutical industry. Because water acts as a solvent for ionic substances, measuring its electrical conductivity provides a sensitive, non-specific indication of the total concentration of dissolved ions. The United States Pharmacopeia (USP) general chapter <645> provides the standardized methodology for measuring water conductivity to ensure it meets purity requirements suitable for pharmaceutical use.
In pharmaceutical manufacturing, water is the most widely used raw material. Impurities in water, such as chlorides, sulfates, sodium, and ammonium, can alter the chemical stability of active pharmaceutical ingredients (APIs) or cause adverse reactions in patients. Historically, specific chemical tests (wet chemistry) were required to detect each ion. However, these tests were time-consuming and prone to sampling errors. Modern compendial standards, such as USP <645>, utilize conductivity as a surrogate test. By adhering to strict conductivity limits, manufacturers can verify that the levels of ionic impurities are below thresholds that would affect product quality or patient safety, all without performing individual ion assays.
Accurate measurement of water conductivity requires precise instrumentation. USP <645> mandates the use of conductivity meters that meet specific performance criteria. Before testing, the instrument must be calibrated using traceable standards. The chapter emphasizes two critical components of the measurement system:
USP <645> distinguishes between "non-temperature-compensated" conductivity (reading the value at the actual temperature) and "temperature-compensated" conductivity (the value referenced to 25C). The standard procedure relies heavily on temperature-compensated data to make pass/fail determinations.
USP <645> outlines a three-stage test procedure. This sequential approach is designed to be robust against legitimate variations in water temperature and carbon dioxide absorption from the atmosphere, which can temporarily increase conductivity readings.
The first stage is designed for rapid, real-time monitoring. The water temperature is measured, and the conductivity is measured without temperature compensation if the temperature is below 25C, or with temperature compensation if the temperature is 25C or higher.
According to the USP <645> tables, if the water temperature and conductivity fall within the defined acceptable zone (e.g., for very pure water, conductivity must be very low regardless of temperature), the water meets the requirements. If the results are outside these limits, the test proceeds to Stage 2.
Stage 2 accounts for the presence of dissolved gases like carbon dioxide, which can dissolve into low-ionic-strength water from the air and artificially elevate conductivity. In this stage, a sample is collected with minimal agitation to prevent gas exchange.
The conductivity is measured, and the temperature is recorded. If the measured conductivity is lower than the limit specified in the Stage 2 table for that specific temperature, the water passes. If the conductivity is higher, it does not necessarily mean the water is impure; it may simply contain excess dissolved gas. Therefore, the test may proceed to Stage 3.
Note on Stage 2: For Purified Water and Water for Injection, the limits are generally stricter in Stage 2 than in Stage 1 because the water quality must be verified under conditions that might include ambient exposure.
If the sample fails Stage 2, Stage 3 is performed to determine if the high conductivity is due to ionic impurities or merely to pH drift (which often correlates with dissolved carbon dioxide forming carbonic acid).
In this stage, the sample is subjected to vigorous agitation or sparging with inert gas to equilibrate the dissolved gases. The pH and conductivity are then measured. USP <645> provides a graph or table relating pH to the allowable conductivity. This relationship is crucial because pure water has a specific neutral pH (around 7.0 at 25C). If the pH drifts significantly toward the acidic or alkaline side, the allowable conductivity limit increases slightly to accommodate the ions related to that pH shift (H or OH).
If the measured conductivity falls below the value indicated by the pH/conductivity curve, the water passes. If it exceeds the value, the water fails the test, indicating excessive ionic contamination beyond acceptable limits.
The result of the USP <645> test is binary: Pass or Fail. If the water passes Stage 1, no further testing is required for that batch or time point. If it fails Stage 1 but passes Stage 2 or Stage 3, it is considered compliant. This flexibility allows for the practical reality of water systems where temperature fluctuations and minor atmospheric gas absorption are inevitable, without compromising the detection of actual ionic contamination.
Implementing USP <645> is not merely about purchasing a meter; the system must be validated. This includes Operational Qualification (OQ) and Performance Qualification (PQ) of the conductivity analyzer. Regular verification of the instrument using standard reference materials (often 1.0 S/cm, 5.0 S/cm, and 10.0 S/cm standards) is required to ensure accuracy. Furthermore, the water system itself must maintain a state of control, as conductivity excursions often serve as early warning signs for deionizing resin exhaustion or other system failures.
USP <645> provides a rigorous, scientifically validated framework for ensuring the ionic purity of water used in pharmaceutical applications. By employing a three-stage approach that differentiates between true ionic contamination and temporary environmental factors like temperature and dissolved carbon dioxide, the standard ensures that pharmacopeial waters are safe for use. Proper calibration, accurate temperature compensation, and strict adherence to the specified stages are essential for compliance and for guaranteeing the quality of the final pharmaceutical product.
